Apr. 14 at 11:40 AM
$JNJ Q1 '26 Earnings Results & Recap
• Reported GAAP EPS of
$2.14 down -53.17% YoY
• Reported revenue of
$24.06B up 9.91% YoY
• Johnson & Johnson increases 2026 guidance with estimated reported sales of
$100.8B or 7.0% at the midpoint, and adjusted EPS of
$11.55 or 7.1% at the midpoint.